Transcatheter Aortic Valve Replacement (TAVR) Market 2021 Clinical Survey Report - Edward Life Sciences, Medtronic, Boston Scientific Corporation, St. Jude Medical

Global Transcatheter Aortic Valve Replacement (TAVR) Market Report 2021-2023

The report provides a valuable source of insightful data for business strategists and competitive analysis of Transcatheter Aortic Valve Replacement (TAVR) Market. It provides the Transcatheter Aortic Valve Replacement (TAVR) industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Transcatheter Aortic Valve Replacement (TAVR) study provides comprehensive data which enhances the understanding, scope and application of this report.

Global market is projected to display a robust growth represented by a high CAGR of 14.70 % during 2018 - 2023.

Inquire for Sample Copy of this Report at:

https://www.marketinsightsreports.com/reports/05202915597/global-transcatheter-aortic-valve-replacement-tavr-market-value-volume-analysis-by-type-of-approach-transfemoral-transapical-by-region-by-country-2018-edition-forecast-to-2023-by-region-north-america-europe-apac-row-by-country-u-s-canada-germany-france-united-kingdom-india-japan-china-brazil-south-africa/inquiry?source=openpr&Mode=11                   

Prominent Players in the global Transcatheter Aortic Valve Replacement (TAVR) market are –

Edward Life Sciences, Medtronic, Boston Scientific Corporation, St. Jude Medical, Jena Valve, Meril Life Sciences Pvt. Ltd. and others.

Industry News and Updates:

Oct. 14, 2020 / -- Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS). The SMall Annuli Randomized To Evolut™ or Sapien (SMART) post-market trial will compare valve safety and performance of the self-expanding Medtronic Evolut™ PRO and PRO+TAVR Systems against the balloon-expandable SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Heart Valves manufactured by Edwards Lifesciences.

Enrolling approximately 700 patients globally, the study will evaluate valve performance in patients with small annuli and those who are candidates for TAV-in-SAV procedures (transcatheter valve implanted inside of a failed surgical valve), which combined, represent more than 40% of the global TAVR market. Due to its focus on small annulus patients, the SMART Trial will enroll predominantly women, which will provide important clinical insight into a currently underrepresented patient population in TAVR literature. The study includes pre-specified endpoints of hemodynamic (blood flow) superiority and clinical non-inferiority with the Evolut platform for mortality, stroke, or rehospitalization at 12 months.

Transcatheter aortic valve replacement has been a ground-breaking advancement in the field of interventional cardiology and cardiovascular surgery. Although, surgical aortic valve replacement is considered the standard treatment, yet 30% of patients are not considered candidates for traditional open heart surgery because of advanced age and presence of multiple comorbidities. TAVR offers this population a less invasive treatment option also with better outcomes. Over the recent years, the global TAVR industry has been growing rapidly mainly due to growing number of elderly population, rising awareness about minimally invasive devices, new device approvals and increasing health expenditure in developing countries. The procedure of transcatheter aortic valve replacement through transfemoral retrograde is the most common catheter-based approach and is performed in approximately 70% to 80% of the total TAVR cases, globally. Hence, this segment holds majority share in the market. This trend is anticipated to continue in the forecast period as well.

Amongst the regions, North America accounts for the largest regional share in the global transcatheter aortic valve replacement market in 2018. However, Asia Pacific is predicted to advance at the highest rate, mainly driven by increase in healthcare expenditure coupled with growing penetration and awareness about technologically advanced heart valve therapies.

Scope of the Report

 -Transcatheter Aortic Valve Replacement (TAVR) Market Size, Share & Forecast
 -Segmental Analysis  Standalone and Chained
 - Chained/Organized Transcatheter Aortic Valve Replacement (TAVR)  Sizing, Growth, Forecast 
 -Market Entry Strategies for Domestic/Foreign Players
 -Policy & Regulatory Landscape
 -Changing Market Trends & Emerging Opportunities
 -Competitive Landscape & Strategic Recommendations

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Browse Full Report at:

https://www.marketinsightsreports.com/reports/05202915597/global-transcatheter-aortic-valve-replacement-tavr-market-value-volume-analysis-by-type-of-approach-transfemoral-transapical-by-region-by-country-2018-edition-forecast-to-2023-by-region-north-america-europe-apac-row-by-country-u-s-canada-germany-france-united-kingdom-india-japan-china-brazil-south-africa?source=openpr&Mode=11

What are the market factors that are explained in the report?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Analytical Tools: The Global Transcatheter Aortic Valve Replacement (TAVR) Market Report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

How we have factored the effect of Covid-19 in our report:

All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

Contact US:
Irfan Tamboli (Head of Sales): Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.